aTyr Pharma develops Physiocrines, a novel class of protein therapeutics, and is currently focusing on developing products for hematologic, immune, and metabolic indications. aTyr Pharma has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. The privately held biotech was founded by Scripps Research Institute Professor Paul Schimmel, and is backed by leading life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.
If you thrive in a fast-paced environment and enjoy creative and challenging work, aTyr Pharma may be the company for you. aTyr Pharma is looking for success minded, team oriented individuals who want to join a dynamic and growing company. aTyr Pharma is results-oriented and focused on achieving our goals.
We are currently recruiting for the following positions: